Table 4.
Inflammatory conditions: treatment modalities and outcomes.
| Treatment modality | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Condition | Observation | Chemotherapy | Corticosteroids | Steroids and immunosuppression | Steroids and chemotherapy | NSAID | Steroids, immunosuppresion, radiotherapy | Steroids and surgery | Surgery | Unknown |
| IgG4-RD n = 20 | 1 (5) | – | 7 (35) | 6 (30) | 3 (15) | 1 (5) | 1 (5) | – | 1 (5) | – |
| IOID n = 20 | 9 (45) | – | 8 (40) | 1 (5) | 1 (5) | – | – | – | 1 (5) | – |
| Sarcoidosis n = 11 | 1 (9.1) | – | 7 (63.6) | – | 2 (18.2) | – | – | – | – | 1 (9.1) |
| Xanthogranulomatous disease n = 8 | – | 2 (25) | – | 2 (25) | 3 (37.5) | – | – | 1 (12.5) | – | – |
| EBV dacryoadenitis n = 2 | 1 (50) | – | 1 (50) | – | – | – | – | – | – | – |
| Viral dacryoadenitis n = 2 | 2 (100) | – | – | – | – | – | – | – | – | – |
| GPA n = 2 | – | – | – | 2 (100) | – | – | – | – | – | – |
| Sjogren’s n = 2 | – | – | – | – | – | – | – | – | 1 (50) | 1 (50) |
| Unspecified vasculitis n = 1 | – | – | 1 (100) | – | – | – | – | – | – | – |
| Eosinophilic asthma n = 1 | – | – | – | 1 (100) | – | – | – | – | – | – |
| Total n = 69 | 14 (20.3) | 2 (2.9) | 24 (34.8) | 12 (17.4) | 9 (13.0) | 1 (1.4) | 1 (1.4) | 1 (1.4) | 3 (4.3) | 2 (2.9) |
All results expressed as: n (% of patients with that specific diagnosis).
EBV Epstein-Barr virus, GPA Granulomatosis with polyangiitis, IOID Idiopathic orbital inflammatory disease, IgG4-RD IgG4-related disease.